Showing results (2801-2810 of 3,166) with videos related to
Sort By:
Pageof 317
Neuro-Oncology|April 12, 2012
MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activityNadiya M Teplyuk, Brit Mollenhauer, Galina Gabriely, et al.Neuro-Oncology|September 26, 2014
Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesisRen-Yuan Bai, Verena Staedtke, Charles M Rudin, et al.Neuro-Oncology|October 1, 2014
The biology of radiosurgery and its clinical applications for brain tumorsDouglas Kondziolka, Samuel M Shin, Andrew Brunswick, et al.Neuro-Oncology|October 11, 2014
Belonging to a network--microRNAs, extracellular vesicles, and the glioblastoma microenvironmentJakub Godlewski, Anna M Krichevsky, Mark D Johnson, et al.Neuro-Oncology|August 8, 2014
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningiomaThomas J Kaley, Patrick Wen, David Schiff, et al.Neuro-Oncology|August 3, 2014
Adult mouse subventricular zones stimulate glioblastoma stem cells specific invasion through CXCL12/CXCR4 signalingNicolas Goffart, Jérôme Kroonen, Emmanuel Di Valentin, et al.Neuro-Oncology|July 6, 2013
Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastomaChristine Lu-Emerson, Matija Snuderl, Nathaniel D Kirkpatrick, et al.Neuro-Oncology|July 6, 2013
High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistanceZhe Bao Wu, Lin Cai, Shao Jian Lin, et al.Neuro-Oncology|July 20, 2014
Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosisStine A Danielsen, Guro E Lind, Matthias Kolberg, et al.Neuro-Oncology|July 24, 2014
Local delivery of cancer-cell glycolytic inhibitors in high-grade gliomaRobert T Wicks, Javad Azadi, Antonella Mangraviti, et al.Pageof 317